Interleukins and redox impairment in type 2 diabetes mellitus: mini-review and pilot study.
Anca UngurianuAnca ZanfirescuDaniela GradinaruConstantin Ionescu-TîrgovișteRucsandra Dănciulescu MiulescuDenisa Marilena MarginaPublished in: Current medical research and opinion (2022)
Several of the assessed parameters may possess prognostic value for diabetics, especially when comparing subgroups with a different smoking history and could prove useful in clinical practice for assessing disease progress and therapeutic efficacy.